-
Part 1 | Session 6 Session 1.3: Key Issues in TAVI
-
Part 1 | Session 7 Session 1.4: Live Cases and Discussions
-
Part 1 | Session 8 Day Close
-
Part 2 | Session 2 Day Welcome: Complex PCI
-
Part 2 | Session 3 Session 2.1: Balloon Revolution
-
Part 2 | Session 4 Session 2.2: Live Cases and Discussions
-
Part 2 | Session 7 Session 2.3: Left Main & Bifurcations
-
Part 2 | Session 8 Session 2.4: Live Cases and Discussion
-
Part 2 | Session 9 Day Close
-
Part 3 | Session 1 Day Welcome: Debates & Controversies
-
Part 3 | Session 2 Session 3.1: Keynote & Debate
-
Part 3 | Session 3 Session 3.2: Live Cases and Discussion
-
Part 3 | Session 5 Session 3.3: Debates
-
Part 3 | Session 6 Day Close
-
Part 1 | Session 1 Day Welcome: Structural Heart Disease
-
Part 1 | Session 2 Session 1.1: Atrioventricular Valve Replacement Beyond TEER?
-
Part 1 | Session 3 Session 1.2: Live Cases and Discussions
Welcome to the on-demand sessions of Transcatheter Interventions Online 2023, broadcast live on 15-17 March 2023. If you missed the live broadcast, here you can access all sessions in full.
TIO 2023 brought together a leading international faculty to create a rich, interactive experience to support the global interventional cardiology community stay abreast of the latest developments in transcatheter treatment strategies. Combining expert opinion and discussion, presentations and live cases from centres of excellence from both sides of the Atlantic, TIO 2023 again delivered best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
The live version of Transcatheter Interventions Online 2023 was CME-accredited. This on-demand version is not.
A CME-accredited version of each session of TIO 2023 is now available on Radcliffe Medical Education.
Key Learning Objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates and Controversies
Faculty Biographies
Didier Tchétché
Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.
In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.
Kendra J Grubb
Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.
Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.
Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…
Ignacio J Amat-Santos
Director, Cardiac Catheterization & Interventional Cardiology
Dr Ignacio J Amat Santos is an interventional cardiologist based in Spain. He is currently the director of cardiac catheterization and interventional cardiology at Hospital Clínico Valladolid.
Dr Amat Santos is the director of cardiac catheterization and interventional cardiology at Hospital Clínico Valladolid. He has clinical and research experience in the percutaneous treatment of coronary and structural heart disease. He is also experienced in clinical cardiology, functional tests and echocardiography.
Dr Amat Santos applied V-WAVE, a device to treat heart failure, for the first time in Europe in his hospital. His scientific activity has given rise to the publication of more than 40 articles and more than a hundred communications in national and international congresses.
Dr Ignacio J Amat-Santos is on the European Cardiology Review Editorial Board.
Darren Mylotte
Consultant Cardiologist
Darren Mylotte is an Irish cardiologist with specialist expertise in interventional and structural heart disease. He undertook his medical education and early professional training in Ireland before pursuing advanced subspecialty and research training in Europe. His career reflects a strong commitment to academic cardiology, combining clinical excellence with advanced research in transcatheter valve therapies.
Academic History
Dr Mylotte graduated from the Royal College of Surgeons in Ireland (RCSI) Medical School in 2001. He obtained Membership of the Royal College of Physicians in Ireland in 2004 and subsequently completed the Irish Cardiology Specialist Training Scheme.
In 2010, he was conferred with the degree of Doctor of Medicine (MD) by the Royal College of Surgeons in Ireland, based on original research. In addition to his MD, he also undertook doctoral-level research leading to a PhD focused on Transcatheter Aortic Valve Implantation (TAVI)…